Cadrenal Therapeutics CVKD
NASDAQ CVKD
$0.99 -0.09 (-8.10%)
As of: Oct 1, 2026 · 12:02 PM EDT

Cadrenal Therapeutics (CVKD) EBITDA (2022 - 2026)

Updated

Cadrenal Therapeutics (CVKD) reported EBITDA of -$3.34 million for Q2 2026, compared with -$3.73 million a year earlier.

Analysis

Cadrenal Therapeutics (CVKD) EBITDA (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Cadrenal Therapeutics' EBITDA came in at -$12 million; for FY2023, it came in at -$7.63 million.

  • By year, EBITDA came in at -$2.7 million in FY2022.
  • The Q2 2026 figure ranks as the highest quarterly EBITDA since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.10 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 8.33 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 999.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 5.09 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 4.63 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -9.70 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.89 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.30 Bn
10 Cadrenal Therapeutics 3.35 Mn -9.27 Mn - -3.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.34 Mn
Jun 30, 2025 -3.73 Mn
Sep 30, 2024 -2.46 Mn
Jun 30, 2024 -2.47 Mn
Mar 31, 2024 -1.76 Mn
Dec 31, 2023 -1.26 Mn
Sep 30, 2023 -1.14 Mn
Jun 30, 2023 -1.03 Mn
Mar 31, 2023 -4.20 Mn
Dec 31, 2022 -1.08 Mn
Sep 30, 2022 -972,285.00
API Access

Cadrenal Therapeutics EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=CVKD&period=max&api_key=YOUR_API_KEY